Plegridy
Generic name: Peginterferon Beta-1a
Drug class:
Interferons
Usage of Plegridy
Plegridy is made from human proteins. Interferons stimulate the body's immune responses to infection or disease.
Plegridy is used to treat relapsing forms of multiple sclerosis (MS) (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) in adults who are 18 to 65 years old.
Plegridy will not cure multiple sclerosis, it will only decrease the frequency of relapse symptoms.
Plegridy is available in a single-dose prefilled pen or a single-dose prefilled syringe.
Plegridy side effects
Get emergency medical help if you have signs of an allergic reaction to Plegridy : hives, itching, bumps on your skin; feeling anxious or light-headed; difficult breathing; swelling of your face, lips, tongue, or throat.
Peginterferon beta-1a can cause life-threatening blood clots in the small blood vessels inside your organs, such as your brain or kidneys. Seek medical help right away if you have symptoms of this condition, such as a fever, tiredness, decreased urination, bruising, or nosebleeds.
Call your doctor at once if you have:
Common Plegridy side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Plegridy
You should not use Plegridy if you are allergic to peginterferon beta-1a.
To make sure Plegridy is safe for you, tell your doctor if you have:
Some people have thoughts about suicide while using Plegridy. Stay alert to changes in your mood or symptoms.
Tell your doctor if you are pregnant or plan to become pregnant.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of peginterferon beta-1a on the baby.
It may not be safe to breastfeed while using Plegridy. Ask your doctor about any risk.
Plegridy is not approved for use by anyone younger than 18 or older than 65 years old.
Relate drugs
- Actimmune
- Alferon N
- Avonex
- Avonex Pen
- Avonex Prefilled Syringe
- Betaseron
- Extavia
- Interferon alfa-n3
- Interferon beta-1a
- Interferon beta-1b
- Interferon gamma-1b
- Peginterferon beta-1a
- Plegridy
- Plegridy Pen
- Plegridy Pen Starter Pack
- Rebif
- Rebif Rebidose
- Rebif Rebidose Titration Pack
How to use Plegridy
Usual Adult Dose of Plegridy for Multiple Sclerosis:
Initial dose: 63 mcg injected suBCutaneously or intramuscularly on day 1, 94 mcg on day 15 (14 days later), reaching the full dose of 125 mcg on day 29 (after another 14 days) Maintenance dose:125 mcg injected subcutaneously or intramuscularly every 14 days Comments: -Patient should be advised to rotate sites for subcutaneous or intramuscular injections. The usual sites for subcutaneous injections are abdomen, back of the upper arm, and thigh. The usual site for intramuscular injections is the thigh. -Prophylactic and concurrent use of analgesics and/or antipyretics may prevent or reduce flu-like symptoms sometimes experienced during treatment.
Warnings
Plegridy can cause serious side effects, including:
Call your healthcare provider right away if you have any of the symptoms listed above.
What other drugs will affect Plegridy
Other drugs may interact with peginterferon beta-1a, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions